RESEARCH REPORTS
889 -- Randomized, Double-Blind, Crossover Comparison of Amlodipine and Valsartan in African-Americans with Hypertension Using 24-Hour Ambulatory Blood Pressure Monitoring
Stephanie Maciejewski, Pharm.D., Syed M. Mohiuddin, M.D., Kathleen A. Packard, Pharm.D., Aryan N. Mooss, M.D., Antonio P. Reyes, M.D., Arash Aryana, M.D., and Daniel E. Hilleman, Pharm.D.
896 -- Pharmacologic Management of Constipation in the Critically Ill Patient
Asad E. Patanwala, Pharm.D., Jacob Abarca, Pharm.D., M.S., Yvonne Huckleberry, Pharm.D., and Brian L. Erstad, Pharm.D., FCCP
BRIEF REPORT
903 -- Disposition of Imatinib and Its Metabolite CGP74588 in a Patient with Chronic Myelogenous Leukemia and Short-Bowel Syndrome
Jan H. Beumer, Pharm.D., Ph.D., James J. Natale, Pharm.D., Theodore F. Lagattuta, B.S., Anastasios Raptis, M.D., and Merrill J. Egorin, M.D.
REVIEWS OF THERAPEUTICS
908 -- Dalbavancin: A Novel Lipoglycopeptide Antibacterial
Scott D. Pope, Pharm.D., and Andrew M. Roecker, Pharm.D.
919 -- Cardiovascular Risks of Cyclooxygenase Inhibition
Zachary A. Stacy, Pharm.D., Paul P. Dobesh, Pharm.D., FCCP, and Toby C. Trujillo, Pharm.D.
PRACTICE INSIGHTS
939 -- Key Articles, Guidelines, and Consensus Papers Relative to the Treatment of Dyslipidemias -- 2005
Matthew K. Ito, Pharm.D., FCCP, Rebecca J. Cheung, Pharm.D. Eric K. Gupta, Pharm.D., Kimberly K. Birtcher, Pharm.D., Pang H. Chong, Pharm.D., Theresa M. Bianco, Pharm.D., and Barry E. Bleske, Pharm.D., FCCP
CASE REPORTS
1011 -- Amphotericin B-Associated Hyperbilirubinemia: Case Report and Review of the Literature
Jacqueline L. Olin, Pharm.D., and Linda M. Spooner, Pharm.D.
1018 -- Thalidomide-Induced Severe Hepatotoxicity
A. James Hanje, M.D., Jennifer L. Shamp, Pharm.D., Fred B. Thomas, M.D., and Greg M. Meis, M.D.
1023 -- Clopidogrel-Induced Hepatotoxicity and Fever
Jennifer A. Ng, Pharm.D., Neil Goldberg, D.O., FACC, FCCP, FACOI, and Mohammad J. Tafreshi, Pharm.D.
ACCP WHITE PAPER
1027 -- The State of Science and Research in Clinical Pharmacy
American College of Clinical Pharmacy: Susan C. Fagan, Pharm.D., FCCP, Daniel Touchette, Pharm.D., M.A., Judith A. Smith, Pharm.D., FCCP, Kevin M. Sowinski, Pharm.D., FCCP, Lisa Dolovich, Pharm.D., M.S., Kari L. Olson, Pharm.D., Kai I. Cheang, Pharm.D., Jill M. Kolesar, Pharm.D., FCCP, and M. Lynn Crismon, Pharm.D., FCCP
ALTERNATIVE VIEWPOINTS
1041 -- Estimation of Glomerular Filtration Rate in the Elderly: Cockcroft-Gault Formula versus Modification of Diet in Renal Disease Formula
Marie-Laure Laroche, M.D., M.Sc., Jean-Pierre Charmes M.D., Ph.D., Aline Marcheix, M.D., Fran¨ois Bouthier, M.D., and Louis Merle, M.D., Ph.D.
1047 -- Orchestrating the Growth of Pharmacy as a Clinical Profession -- A Comment
Carla B. Frye, Pharm.D.
1049 -- Implications of Thiazolidinedione Use and Cardiovascular Risk: Is It All About the Sugar?
Mori J. Krantz, M.D., FACC